-  - Diferencia - Volumen Bid- Ask- Capitalización de mecado Dividendo A. P/E Ratio
-USD - -
Volumen de negocios: -
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 4.08 mil millonesUSD - -

Descripción de negocio

Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioning itself as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative uses of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. The technology portfolio is built around active pharmaceutical ingredients (APIs) and performance chemicals and comprises hazardous reactions, low-temperature and high-pressure reactions as well as continuous processing.
 

Consejo de gestión & Consejo de supervisión

CEO
Dr. Markus Blocher
Consejo de gestión
Marlene Born, Karin Krause, Dr. Stephan Kirschbaum, Dr. Urs Brändli, Dr. Thomas Rosatzin, Dr. Robert Dahinden, Dr. Rolf Schaller
Consejo de supervisión
Dr. Markus Blocher, Dr. Pierre-Alain Ruffieux, Dr. Bernhard Urwyler
 

Datos de la empresa

Nombre: Dottikon ES Holding AG
Dirección: Hembrunnstrasse 17,CH-5605 Dottikon
Teléfono: +41-56-616-8111
Fax: -
E-mail: info@dottikon.com
Internet: www.dottikon.com
Industria: Commodities
Sector: Chemicals
Subsector: Chemicals, diversified
Fin del año financiero: 31/03
Acciones de libre circulación: 16.20%
Fecha de OPI: -

Relación con inversores

Nombre: Marlene Born
IR teléfono: +41-56-616-8201
IR-fax: -
IR e-mail: investor-relations@d...kon.com investor-relations@dottikon.com

Accionistas mayoritarios

Markus Blocher
 
64.74%
Otros
 
19.96%
Peter Grogg
 
7.00%
Miriam Baumann
 
5.10%
UBS Fund Management AG
 
3.20%